Total Debt Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual total debt in 2023 was 14.8 Million TWD , down -33.73% from previous year.
PharmaEngine, Inc.'s latest quarterly total debt in 2024 Q2 was 10.99 Million TWD , down -14.82% from previous quarter.
PharmaEngine, Inc. reported annual total debt of 22.34 Million TWD in 2022, up 194.3% from previous year.
PharmaEngine, Inc. reported annual total debt of 7.59 Million TWD in 2021, down -65.61% from previous year.
PharmaEngine, Inc. reported quarterly total debt of 12.9 Million TWD for 2024 Q1, down -12.86% from previous quarter.
PharmaEngine, Inc. reported quarterly total debt of 20.47 Million TWD for 2023 Q1, down -8.38% from previous quarter.

Annual Total Debt Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Debt of PharmaEngine, Inc. (2023 - 2009)

Year	Total Debt	Total Debt Growth
2023	14.8 Million TWD	-33.73%
2022	22.34 Million TWD	194.3%
2021	7.59 Million TWD	-65.61%
2020	22.07 Million TWD	-33.83%
2019	33.36 Million TWD	2799.13%
2018	1.15 Million TWD	82.12%
2017	632 Thousand TWD	111.37%
2016	299 Thousand TWD	-92.36%
2015	3.91 Million TWD	102.9%
2014	1.92 Million TWD	-31.72%
2013	2.82 Million TWD	82.85%
2012	1.54 Million TWD	-6.76%
2011	1.65 Million TWD	-45.89%
2010	3.06 Million TWD	106.47%
2009	1.48 Million TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	10.99 Million TWD	-14.82%
2024 Q1	12.9 Million TWD	-12.86%
2023 Q1	20.47 Million TWD	-8.38%
2023 Q3	16.7 Million TWD	-10.15%
2023 Q4	14.8 Million TWD	-11.36%
2023 FY	14.8 Million TWD	-33.73%
2023 Q2	18.59 Million TWD	-9.19%
2022 Q1	5.52 Million TWD	-27.26%
2022 Q3	1.28 Million TWD	-59.92%
2022 Q4	22.34 Million TWD	1643.06%
2022 FY	22.34 Million TWD	194.3%
2022 Q2	3.19 Million TWD	-42.08%
2021 Q2	16.02 Million TWD	-13.47%
2021 Q3	9.73 Million TWD	-39.25%
2021 Q4	7.59 Million TWD	-21.98%
2021 Q1	18.51 Million TWD	-16.14%
2021 FY	7.59 Million TWD	-65.61%
2020 Q4	22.07 Million TWD	-10.61%
2020 Q3	24.7 Million TWD	-9.45%
2020 FY	22.07 Million TWD	-33.83%
2020 Q1	30.45 Million TWD	-8.74%
2020 Q2	27.27 Million TWD	-10.43%
2019 Q3	9.75 Million TWD	-12.58%
2019 Q4	33.36 Million TWD	242.14%
2019 FY	33.36 Million TWD	2799.13%
2019 Q1	11.35 Million TWD	886.19%
2019 Q2	11.15 Million TWD	-1.71%
2018 Q1	342 Thousand TWD	-45.89%
2018 Q4	1.15 Million TWD	19.4%
2018 Q3	964 Thousand TWD	-23.06%
2018 Q2	1.25 Million TWD	266.37%
2018 FY	1.15 Million TWD	82.12%
2017 Q1	232 Thousand TWD	-22.41%
2017 Q4	632 Thousand TWD	-2.92%
2017 Q3	651 Thousand TWD	11.28%
2017 Q2	585 Thousand TWD	152.16%
2017 FY	632 Thousand TWD	111.37%
2016 Q3	1.34 Million TWD	-47.01%
2016 FY	299 Thousand TWD	-92.36%
2016 Q2	2.54 Million TWD	65.58%
2016 Q1	1.53 Million TWD	-60.81%
2016 Q4	299 Thousand TWD	-77.79%
2015 Q3	822 Thousand TWD	-11.23%
2015 Q4	3.91 Million TWD	376.16%
2015 Q2	926 Thousand TWD	-58.68%
2015 Q1	2.24 Million TWD	16.17%
2015 FY	3.91 Million TWD	102.9%
2014 Q3	2.12 Million TWD	-34.59%
2014 Q2	3.25 Million TWD	316.39%
2014 Q1	781 Thousand TWD	-72.35%
2014 FY	1.92 Million TWD	-31.72%
2014 Q4	1.92 Million TWD	-9.31%
2013 Q2	2.62 Million TWD	367.86%
2013 Q4	2.82 Million TWD	15.83%
2013 Q3	2.43 Million TWD	-6.91%
2013 Q1	560 Thousand TWD	-63.75%
2013 FY	2.82 Million TWD	82.85%
2012 FY	1.54 Million TWD	-6.76%
2012 Q2	2.89 Million TWD	364.53%
2012 Q3	3.63 Million TWD	25.67%
2012 Q1	623 Thousand TWD	-62.4%
2012 Q4	1.54 Million TWD	-57.52%
2011 Q4	1.65 Million TWD	0.0%
2011 FY	1.65 Million TWD	-45.89%
2010 FY	3.06 Million TWD	106.47%
2009 FY	1.48 Million TWD	0.0%

Peer Total Debt Comparison of PharmaEngine, Inc.

Name	Total Debt	Total Debt Difference
Great Novel Therapeutics Biotech & Medicals	14.37 Million TWD	-3.019%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	417.01 Million TWD	96.449%
Visgeneer Inc.	158.6 Million TWD	90.663%
Genomics BioSci & Tech. Co.,Ltd.	283.61 Million TWD	94.778%
Advagene Biopharma Co., Ltd.	870 Thousand TWD	-1602.184%
Sagittarius Life Science Corp	13.32 Million TWD	-11.154%
NaviFUS Corp.	32.69 Million TWD	54.703%
BioGend Therapeutics Co., Ltd.	13.09 Million TWD	-13.115%
Shine-On BioMedical Co.,Ltd.	538 Thousand TWD	-2652.602%
TaiRx, Inc.	12.28 Million TWD	-20.536%
Andros Pharmaceuticals Co.,Ltd	27.12 Million TWD	45.397%
Lin BioScience, Inc.	42.87 Million TWD	65.458%
TaiwanJ Pharmaceuticals Co., Ltd.	1.17 Million TWD	-1164.646%
Lumosa Therapeutics Co., Ltd.	12.61 Million TWD	-17.439%
Anti-Microbial Savior BioteQ Co., Ltd	1.38 Million TWD	-970.788%
BioLASCO Taiwan Co., Ltd.	58.2 Million TWD	74.558%
SYN-TECH Chem. & Pharm. Co., Ltd.	402.75 Million TWD	96.323%
Sunmax Biotechnology Co., Ltd.	174.08 Million TWD	91.493%
RBC Bioscience Corporation	487.36 Million TWD	96.961%
Bio Preventive Medicine Corp.	113.44 Million TWD	86.946%
Syngen Biotech Co.,Ltd.	681.76 Million TWD	97.828%
G&E Herbal Biotechnology Co., Ltd.	5.43 Million TWD	-172.675%
AP Biosciences Inc	82.07 Million TWD	81.958%
EirGenix Inc.	465.16 Million TWD	96.816%
Enimmune corporation	45.73 Million TWD	67.619%
Lukas Biomedical Inc.	82.55 Million TWD	82.062%
GlycoNex Incorporation	900 Thousand TWD	-1545.444%
BRIM Biotechnology, Inc.	3.59 Million TWD	-312.277%
Level Biotechnology Inc.	13.5 Million TWD	-9.68%
Pharmosa Biopharm Inc.	144.36 Million TWD	89.742%
TaiMed Biologics Inc.	750.85 Million TWD	98.028%
Mycenax Biotech Inc.	726.27 Million TWD	97.961%
SynCore Biotechnology Co.,Ltd	2.11 Million TWD	-600.52%
Eusol Biotech Co.,Ltd.	4.35 Million TWD	-240.124%
Taiwan Advance Bio-Pharmaceutical Inc.	320.13 Million TWD	95.374%
Feng Chi Biotech Corp.	10.79 Million TWD	-37.146%
NeoCore Technology Co., Ltd.	96.89 Million TWD	84.716%
TWi Biotechnology, Inc.	7.97 Million TWD	-85.786%
Neith Corporation	3.54 Million TWD	-318.215%
Sunny Pharmtech Inc.	391.42 Million TWD	96.217%
VBI	- TWD	-Infinity%
BiOptic Inc.	93.19 Million TWD	84.11%
Ever Supreme Bio Technology Co., Ltd	5.89 Million TWD	-151.085%
Sinew Pharma Inc.	6.46 Million TWD	-129.1%
Greenyn Biotechnology Co., Ltd	196.13 Million TWD	92.45%
GeneReach Biotechnology Corp.	257.03 Million TWD	94.239%
CHO Pharma, Inc.	- TWD	-Infinity%
Medigen Biotechnology Corp.	2.91 Billion TWD	99.491%
3D Global Biotech Inc.	10.37 Million TWD	-42.682%
Senhwa Biosciences, Inc.	9.6 Million TWD	-54.244%
Intech Biopharm Corporation	1.43 Billion TWD	98.968%
Oneness Biotech Co., Ltd.	397.95 Million TWD	96.279%
TCI GENE Inc.	6.79 Million TWD	-117.94%
MegaPro Biomedical Co., Ltd	8.31 Million TWD	-78.036%
Taiwan Bio Therapeutics Co., Ltd	268.62 Million TWD	94.487%
NatureWise Biotech & Medicals Corporation	10.68 Million TWD	-38.635%
Savior Lifetec Corporation	270.37 Million TWD	94.523%
TaiGen Biopharmaceuticals Holdings Limited	74.68 Million TWD	80.172%
OBI Pharma, Inc.	501.05 Million TWD	97.044%
Meribank Biotech Co., Ltd	34.03 Million TWD	56.494%
Medigen Vaccine Biologics Corporation	1.97 Billion TWD	99.25%
Acepodia, Inc.	273.81 Million TWD	94.592%
Caliway Biopharmaceuticals Co., Ltd.	20.45 Million TWD	27.613%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Total Debt Summary of PharmaEngine, Inc.

Annual Total Debt Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Debt of PharmaEngine, Inc. (2023 - 2009)

Peer Total Debt Comparison of PharmaEngine, Inc.